Hoser Ingeniería, a company with more than 30 years of experience in the sale and distribution of medical imaging equipment, will be participating in Expo Salud 2024. As exclusive representatives of GE Healthcare in Chile, Hoser Ingeniería has been a fundamental pillar in the supply of advanced technologies for medical diagnostics, consolidating its position as a leader in the healthcare sector. For more than three decades, Hoser has been synonymous with quality, reliability and vanguard in the healthcare industry. It specialises in the distribution of ultrasound, bone densitometry, X-ray and mammography equipment, providing state-of-the-art technological solutions that meet the needs of medical professionals and improve patient care. At Expo Salud 2024, Hoser Ingeniería will present the latest in medical technology, highlighting a selection of internationally recognised equipment. Its catalogue includes the Crystal Nova and Pristina 3D mammographs, the latter chosen by TIME magazine as a Best Invention of 2019, and the Discovery 656HD and Definium Pace digital radiology equipment, which integrate advanced image processing controlled by artificial intelligence, increasing the precision and efficiency of medical diagnoses. GE Healthcare equipment is distinguished not only by its superior image quality, but also by its focus on patient comfort. We know that the patient experience is critical in medical practice, and these products are designed to provide maximum comfort during procedures, without compromising diagnostic accuracy. They offer tools that not only enable accurate diagnoses, but also adapt to the changing needs of the industry, and provide products that combine state-of-the-art technology with ease of use and excellent technical service, ensuring that customers receive the support they need to keep their equipment in optimum condition. At their stand you can get up close and personal with their innovations, talk to experts and discover how their equipment can transform medical practice and improve patient outcomes.